Clara Bien Peek (Clara B Peek)

ORCID

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 11

Top Venues

Nature communications

Science advances

Genes & development

This page only lists publications with an associated author ORCID identifier.

Publications

Mary M McDermott, Christopher R Martens, Kathryn J Domanchuk, Dongxue Zhang, Clara Bien Peek, Michael H Criqui, Luigi Ferruci, Philip Greenland, Jack M Guralnik, Karen J Ho, Melina R Kibbe, Kate Kosmac, Donald Lloyd-Jones, Charlotte A Peterson, Robert Sufit, Lu Tian, Stephanie Wohlgemuth, Lihui Zhao, Pei Zhu, Christiaan Leeuwenburgh
Nicotinamide riboside for peripheral artery disease: the NICE randomized clinical trial. Nature communications 15 (1) (2024)
Mary M McDermott, Christopher R Martens, Kathryn J Domanchuk, Dongxue Zhang, Clara Bien Peek, Michael H Criqui, Luigi Ferruci, Philip Greenland, Jack M Guralnik, Karen J Ho, Melina R Kibbe, Kate Kosmac, Donald Lloyd-Jones, Charlotte A Peterson, Robert Sufit, Lu Tian, Stephanie Wohlgemuth, Lihui Zhao, Pei Zhu, Christiaan Leeuwenburgh
Nicotinamide riboside for peripheral artery disease: the NICE randomized clinical trial. Nature communications 15 (1) (2024)
Mary M McDermott, Christopher R Martens, Kathryn J Domanchuk, Dongxue Zhang, Clara Bien Peek, Michael H Criqui, Luigi Ferruci, Philip Greenland, Jack M Guralnik, Karen J Ho, Melina R Kibbe, Kate Kosmac, Donald Lloyd-Jones, Charlotte A Peterson, Robert Sufit, Lu Tian, Stephanie Wohlgemuth, Lihui Zhao, Pei Zhu, Christiaan Leeuwenburgh
Nicotinamide riboside for peripheral artery disease: the NICE randomized clinical trial. Nature communications 15 (1) (2024)
Mary M McDermott, Christopher R Martens, Kathryn J Domanchuk, Dongxue Zhang, Clara Bien Peek, Michael H Criqui, Luigi Ferruci, Philip Greenland, Jack M Guralnik, Karen J Ho, Melina R Kibbe, Kate Kosmac, Donald Lloyd-Jones, Charlotte A Peterson, Robert Sufit, Lu Tian, Stephanie Wohlgemuth, Lihui Zhao, Pei Zhu, Christiaan Leeuwenburgh
Nicotinamide riboside for peripheral artery disease: the NICE randomized clinical trial. Nature communications 15 (1) (2024)
Mary M McDermott, Christopher R Martens, Kathryn J Domanchuk, Dongxue Zhang, Clara Bien Peek, Michael H Criqui, Luigi Ferruci, Philip Greenland, Jack M Guralnik, Karen J Ho, Melina R Kibbe, Kate Kosmac, Donald Lloyd-Jones, Charlotte A Peterson, Robert Sufit, Lu Tian, Stephanie Wohlgemuth, Lihui Zhao, Pei Zhu, Christiaan Leeuwenburgh
Nicotinamide riboside for peripheral artery disease: the NICE randomized clinical trial. Nature communications 15 (1) (2024)
Mary M McDermott, Christopher R Martens, Kathryn J Domanchuk, Dongxue Zhang, Clara Bien Peek, Michael H Criqui, Luigi Ferruci, Philip Greenland, Jack M Guralnik, Karen J Ho, Melina R Kibbe, Kate Kosmac, Donald Lloyd-Jones, Charlotte A Peterson, Robert Sufit, Lu Tian, Stephanie Wohlgemuth, Lihui Zhao, Pei Zhu, Christiaan Leeuwenburgh
Publisher Correction: Nicotinamide riboside for peripheral artery disease: the NICE randomized clinical trial. Nature communications 15 (1) (2024)
Mary M McDermott, Christopher R Martens, Kathryn J Domanchuk, Dongxue Zhang, Clara Bien Peek, Michael H Criqui, Luigi Ferruci, Philip Greenland, Jack M Guralnik, Karen J Ho, Melina R Kibbe, Kate Kosmac, Donald Lloyd-Jones, Charlotte A Peterson, Robert Sufit, Lu Tian, Stephanie Wohlgemuth, Lihui Zhao, Pei Zhu, Christiaan Leeuwenburgh
Nicotinamide riboside for peripheral artery disease: the NICE randomized clinical trial. Nature communications 15 (1) (2024)
Mary M McDermott, Christopher R Martens, Kathryn J Domanchuk, Dongxue Zhang, Clara Bien Peek, Michael H Criqui, Luigi Ferruci, Philip Greenland, Jack M Guralnik, Karen J Ho, Melina R Kibbe, Kate Kosmac, Donald Lloyd-Jones, Charlotte A Peterson, Robert Sufit, Lu Tian, Stephanie Wohlgemuth, Lihui Zhao, Pei Zhu, Christiaan Leeuwenburgh
Publisher Correction: Nicotinamide riboside for peripheral artery disease: the NICE randomized clinical trial. Nature communications 15 (1) (2024)
Mary M McDermott, Christopher R Martens, Kathryn J Domanchuk, Dongxue Zhang, Clara Bien Peek, Michael H Criqui, Luigi Ferruci, Philip Greenland, Jack M Guralnik, Karen J Ho, Melina R Kibbe, Kate Kosmac, Donald Lloyd-Jones, Charlotte A Peterson, Robert Sufit, Lu Tian, Stephanie Wohlgemuth, Lihui Zhao, Pei Zhu, Christiaan Leeuwenburgh
Nicotinamide riboside for peripheral artery disease: the NICE randomized clinical trial. Nature communications 15 (1) (2024)
Mattia Quattrocelli, Michelle Wintzinger, Karen Miz, Daniel C Levine, Clara Bien Peek, Joseph T Bass, Elizabeth M McNally
Muscle mitochondrial remodeling by intermittent glucocorticoid drugs requires an intact circadian clock and muscle PGC1α. Science advances 8 (7) (2022)
Pei Zhu, Noah X Hamlish, Abhishek Vijay Thakkar, Adam W T Steffeck, Emily J Rendleman, Nabiha H Khan, Nathan J Waldeck, Andrew W DeVilbiss, Misty S Martin-Sandoval, Thomas P Mathews, Navdeep S Chandel, Clara Bien Peek
BMAL1 drives muscle repair through control of hypoxic NAD + regeneration in satellite cells. Genes & development 36 (3-4) (2022)

Clara Bien Peek.css-eqlu8i{font-size:small;padding-left:4px;} (Clara B Peek)

Publication Activity (10 Years)

Top Topics

Top Venues

Clara Bien Peek (Clara B Peek)